Public-registry site landscape for NCT04504279, a Atopic Dermatitis study sponsored by Forte Biosciences, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04504279 (registry record) |
| Sponsor | Forte Biosciences, Inc. |
| Condition(s) | Atopic Dermatitis |
| Phase | PHASE2 |
| Listed sites | 15 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04504279 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →